137 related articles for article (PubMed ID: 24141780)
1. RSK2 regulates endocytosis of FGF receptor 1 by phosphorylation on serine 789.
Nadratowska-Wesolowska B; Haugsten EM; Zakrzewska M; Jakimowicz P; Zhen Y; Pajdzik D; Wesche J; Wiedlocha A
Oncogene; 2014 Oct; 33(40):4823-36. PubMed ID: 24141780
[TBL] [Abstract][Full Text] [Related]
2. ERK-mediated phosphorylation of fibroblast growth factor receptor 1 on Ser777 inhibits signaling.
Zakrzewska M; Haugsten EM; Nadratowska-Wesolowska B; Oppelt A; Hausott B; Jin Y; Otlewski J; Wesche J; Wiedlocha A
Sci Signal; 2013 Feb; 6(262):ra11. PubMed ID: 23405013
[TBL] [Abstract][Full Text] [Related]
3. A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1.
Frödin M; Jensen CJ; Merienne K; Gammeltoft S
EMBO J; 2000 Jun; 19(12):2924-34. PubMed ID: 10856237
[TBL] [Abstract][Full Text] [Related]
4. Nedd4-1 binds and ubiquitylates activated FGFR1 to control its endocytosis and function.
Persaud A; Alberts P; Hayes M; Guettler S; Clarke I; Sicheri F; Dirks P; Ciruna B; Rotin D
EMBO J; 2011 Jul; 30(16):3259-73. PubMed ID: 21765395
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine phosphorylation of NEDD4 activates its ubiquitin ligase activity.
Persaud A; Alberts P; Mari S; Tong J; Murchie R; Maspero E; Safi F; Moran MF; Polo S; Rotin D
Sci Signal; 2014 Oct; 7(346):ra95. PubMed ID: 25292214
[TBL] [Abstract][Full Text] [Related]
6. p90 ribosomal S6 kinase 2 is associated with and dephosphorylated by protein phosphatase 2Cdelta.
Doehn U; Gammeltoft S; Shen SH; Jensen CJ
Biochem J; 2004 Sep; 382(Pt 2):425-31. PubMed ID: 15206906
[TBL] [Abstract][Full Text] [Related]
7. Association of fibroblast growth factor receptor 1 with the adaptor protein Grb14. Characterization of a new receptor binding partner.
Reilly JF; Mickey G; Maher PA
J Biol Chem; 2000 Mar; 275(11):7771-8. PubMed ID: 10713090
[TBL] [Abstract][Full Text] [Related]
8. A role for extracellular and transmembrane domains of Sef in Sef-mediated inhibition of FGF signaling.
Kovalenko D; Yang X; Chen PY; Nadeau RJ; Zubanova O; Pigeon K; Friesel R
Cell Signal; 2006 Nov; 18(11):1958-66. PubMed ID: 16603339
[TBL] [Abstract][Full Text] [Related]
9. Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation.
Cho YY; Yao K; Kim HG; Kang BS; Zheng D; Bode AM; Dong Z
Cancer Res; 2007 Sep; 67(17):8104-12. PubMed ID: 17804722
[TBL] [Abstract][Full Text] [Related]
10. FGFR3 activates RSK2 to mediate hematopoietic transformation through tyrosine phosphorylation of RSK2 and activation of the MEK/ERK pathway.
Kang S; Dong S; Gu TL; Guo A; Cohen MS; Lonial S; Khoury HJ; Fabbro D; Gilliland DG; Bergsagel PL; Taunton J; Polakiewicz RD; Chen J
Cancer Cell; 2007 Sep; 12(3):201-14. PubMed ID: 17785202
[TBL] [Abstract][Full Text] [Related]
11. RSK2 drives cell motility by serine phosphorylation of LARG and activation of Rho GTPases.
Shi GX; Yang WS; Jin L; Matter ML; Ramos JW
Proc Natl Acad Sci U S A; 2018 Jan; 115(2):E190-E199. PubMed ID: 29279389
[TBL] [Abstract][Full Text] [Related]
12. Indirubin-3'-monoxime inhibits autophosphorylation of FGFR1 and stimulates ERK1/2 activity via p38 MAPK.
Zhen Y; Sørensen V; Jin Y; Suo Z; Wiedłocha A
Oncogene; 2007 Sep; 26(44):6372-85. PubMed ID: 17533378
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation.
Carrière A; Cargnello M; Julien LA; Gao H; Bonneil E; Thibault P; Roux PP
Curr Biol; 2008 Sep; 18(17):1269-77. PubMed ID: 18722121
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor receptor 3 associates with and tyrosine phosphorylates p90 RSK2, leading to RSK2 activation that mediates hematopoietic transformation.
Kang S; Elf S; Dong S; Hitosugi T; Lythgoe K; Guo A; Ruan H; Lonial S; Khoury HJ; Williams IR; Lee BH; Roesel JL; Karsenty G; Hanauer A; Taunton J; Boggon TJ; Gu TL; Chen J
Mol Cell Biol; 2009 Apr; 29(8):2105-17. PubMed ID: 19223461
[TBL] [Abstract][Full Text] [Related]
15. p90 ribosomal S6 kinase 2 exerts a tonic brake on G protein-coupled receptor signaling.
Sheffler DJ; Kroeze WK; Garcia BG; Deutch AY; Hufeisen SJ; Leahy P; Brüning JC; Roth BL
Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4717-22. PubMed ID: 16537434
[TBL] [Abstract][Full Text] [Related]
16. Activation of RSK by UV-light: phosphorylation dynamics and involvement of the MAPK pathway.
Mérienne K; Jacquot S; Zeniou M; Pannetier S; Sassone-Corsi P; Hanauer A
Oncogene; 2000 Aug; 19(37):4221-9. PubMed ID: 10980595
[TBL] [Abstract][Full Text] [Related]
17. Antibody-induced dimerization of FGFR1 promotes receptor endocytosis independently of its kinase activity.
Opaliński Ł; Sokołowska-Wędzina A; Szczepara M; Zakrzewska M; Otlewski J
Sci Rep; 2017 Aug; 7(1):7121. PubMed ID: 28769084
[TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor stimulates the transcriptional and neuroprotective activity of myocyte-enhancer factor 2C through an ERK1/2-RSK2 signaling cascade.
Wang Y; Liu L; Xia Z
J Neurochem; 2007 Aug; 102(3):957-66. PubMed ID: 17630987
[TBL] [Abstract][Full Text] [Related]
19. Endocytosis and Transport of Growth Factor Receptors in Peripheral Axon Regeneration: Novel Lessons from Neurons Expressing Lysine-Deficient FGF Receptor Type 1 in vitro.
Hausott B; Förste A; Zach F; Mangger S; Haugsten EM; Klimaschewski L
Anat Rec (Hoboken); 2019 Aug; 302(8):1268-1275. PubMed ID: 30950230
[TBL] [Abstract][Full Text] [Related]
20. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.
Hart KC; Robertson SC; Kanemitsu MY; Meyer AN; Tynan JA; Donoghue DJ
Oncogene; 2000 Jul; 19(29):3309-20. PubMed ID: 10918587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
